test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APLSApellis Pharmaceuticals Inc
Recent Activity
Increased 2.45%
11.74%
$342.932M
11.891M shares@ $28.84 avg price
ANABAnaptysbio Inc
Recent Activity
Increased 3.65%
8.94%
$261.132M
7.795M shares@ $33.5 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Increased 3.2%
7.51%
$219.123M
4.288M shares@ $51.1 avg price
JAZZJazz Pharmaceuticals Plc
Recent Activity
Increased 68.3%
6.51%
$190.118M
1.706M shares@ $111.41 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 17.49%
1.38%
$40.276M
352,464 shares@ $114.27 avg price
DYNDyne Therapeutics Inc
Recent Activity
Increased 30.12%
0.69%
$19.959M
555,644 shares@ $35.92 avg price
ATRAAtara Biotherapeutics Inc
Recent Activity
Increased 15.31%
0.14%
$3.812M
468,938 shares@ $8.14 avg price